The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V03 | All other therapeutic products | |
| 3 | V03A | All other therapeutic products | |
| 4 | V03AC | Iron chelating agents | |
| 5 | V03AC03 | Deferasirox |
| Active Ingredient | Description | |
|---|---|---|
| Deferasirox |
Deferasirox is an orally active chelator that is highly selective for iron (III). It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio. Deferasirox promotes excretion of iron, primarily in the faeces. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| EXJADE Dispersible tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| EXJADE Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| EXJADE Granules in sachet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| JADENU Film-coated tablet / Granules | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
